Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Bariatric Surgery

Sleeve gastrectomy ameliorates alveolar structures and surfactant protein expression in lungs of obese and diabetic rats

Abstract

Background

Bariatric surgeries have been shown to be effective in reversing damaged pulmonary function in individuals suffering from obesity and type 2 diabetes mellitus, whereas its underlying mechanisms remain largely unknown.

Methods

Sleeve gastrectomy (SG) was performed on obese and diabetic Wistar rats, and their pulmonary function and lung tissues were compared to sham-operated (SH) obese and diabetic rats, and age-matched healthy controls (C) to explore the improvements in microstructures and expression of surfactant protein (SP)-A and -C at postoperative 4th, 8th, and 12th week.

Result

Apart from the profound metabolic changes and improvement in pulmonary function, lung volume was restored along with an improved diffusion capacity noted by thinned capillary basement membrane and decreased harmonic mean length of diffusion barrier in SG rats. The digital slices of light microscope showed the general changes brought on by the SG, including normalized basic structures, ameliorated inflammatory status, as well as reduced lipid deposition, where the hydroxyproline (HYP), triglyceride (TG) assays, and electron microscope further suggested that the improvement in alveolar structures lies in reduced collagen fibers, lipids and septal tissues, increased capillary blood, and normalized alveolar type 2 (AT2) cells. Besides, disrupted SP-A and SP-C expression were also normalized after SG.

Conclusion

The improvement of lung function after SG is related to the ameliorated alveolar structures, and surface protein expression induced by weight loss and improved glucose metabolism.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Comparisons of metabolic parameters.
Fig. 2: Alterations of basic morphology and tissue properties of lungs under LM.
Fig. 3: Representative microstructures of lungs at the postoperative week 12 under EM.
Fig. 4: The positive effect of SG on tissue property, lung volume, alveolar structures and the morphology of AT2 cells.
Fig. 5: The representative bands of SP-A and SP-C and comparison of relative intensity among groups.

Similar content being viewed by others

Data availability

Research data of current study is available at R.R., J.L., Q.X., M.Z., Y.X., Z.Y., J.Z., Y.C., Z.M., S.H., G.Z. (2020), “Data for: Sleeve gastrectomy ameliorates alveolar structures and surfactant protein expression in lungs of obese and diabetic rats”, Mendeley Data, V2, https://doi.org/10.17632/5nn793z99j.2.

References

  1. Prentki M, Nolan CJ. Islet β cell failure in type 2 diabetes. J Clin Invest. 2006;116:1802–12.

    CAS  PubMed  PubMed Central  Google Scholar 

  2. Harding HP, Ron D. Endoplasmic reticulum stress and the development of diabetes. a review. Diabetes. 2002;51(Suppl 3):S455–61.

    Google Scholar 

  3. Sandler M. Is the lung a ‘target organ’ in diabetes mellitus? JAMA Int Med. 1990;150:1385–8.

    CAS  Google Scholar 

  4. Conway BN, May ME, Fischl A, Frisbee J, Han X, Blot WJ. Cause-specific mortality by race in low-income Black and White people with Type 2 diabetes. Diabet Med. 2015;32:33–41.

    CAS  PubMed  Google Scholar 

  5. van den Borst B, Gosker HR, Zeegers MP, Schols AMWJ. Pulmonary function in diabetes: a metaanalysis. Chest. 2010;138:393–406.

    PubMed  Google Scholar 

  6. Chatila WM, Thomashow BM, Minai OA, Criner GJ, Make BJ. Comorbidities in chronic obstructive pulmonary disease. Proc Am Thorac. Soc. 2008;5:549–55.

    PubMed  PubMed Central  Google Scholar 

  7. Chance WW, Rhee C, Yilmaz C, Dane DM, Pruneda ML, Raskin P, et al. Diminished alveolar microvascular reserves in type 2 diabetes reflect systemic microangiopathy. Diabetes Care. 2008;31:1596–601.

    PubMed  PubMed Central  Google Scholar 

  8. Hsia CC, Raskin P. The diabetic lung: relevance of alveolar microangiopathy for the use of inhaled insulin. Am J Med. 2005;118:205–11.

    CAS  PubMed  Google Scholar 

  9. Niranjan V, McBrayer DG, Ramirez LC, Raskin P, Hsia CC. Glycemic control and cardiopulmonary function in patients with insulin-dependent diabetes mellitus. Am J Med. 1997;103:504–13.

    CAS  PubMed  Google Scholar 

  10. Schuyler MR, Niewoehner DE, Inkley SR, Kohn R. Abnormal lung elasticity in juvenile diabetes mellitus. Am Rev Respir. Dis. 1976;113:37–41.

    CAS  PubMed  Google Scholar 

  11. Sandler M, Bunn AE, Stewart RI. Cross-section study of pulmonary function in patients with insulin-dependent diabetes mellitus. Am Rev Respir Dis. 1987;135:223–9.

    CAS  PubMed  Google Scholar 

  12. Goldman MD. Lung dysfunction in diabetes. Diabetes Care. 2003;26:1915–8.

    PubMed  Google Scholar 

  13. Yeh H-C, Punjabi NM, Wang N-Y, Pankow JS, Duncan BB, Cox CE, et al. Cross-sectional and prospective study of lung function in adults with type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) studys. Diabetes Care. 2008;31:741–6.

    PubMed  Google Scholar 

  14. Weynand B, Jonckheere A, Frans A, Rahier J. Diabetes mellitus induces a thickening of the pulmonary basal lamina. Respiration. 1999;66:14–9.

    CAS  PubMed  Google Scholar 

  15. López-Cano C, Lecube A, García-Ramírez M, Muñoz X, Sánchez E, Seminario A, et al. Serum surfactant protein D as a biomarker for measuring lung involvement in obese patients with type 2 diabetes. J Clin Endocrinol Metab. 2017;102:4109–16.

    PubMed  Google Scholar 

  16. Coya JM, Akinbi HT, Sáenz A, Yang L, Weaver TE, Casals C. Natural anti-infective pulmonary proteins: in vivo cooperative action of surfactant protein SP-A and the lung antimicrobial peptide SP-BN. J Immunol. 2015;195:1628–36.

    CAS  PubMed  PubMed Central  Google Scholar 

  17. Kadoya C, Lee B-W, Ogami A, Oyabu T, Nishi K-i, Yamamoto M, et al. Analysis of pulmonary surfactant in rat lungs after inhalation of nanomaterials: Fullerenes, nickel oxide and multi-walled carbon nanotubes. Nanotoxicology. 2016;10:194–203.

    CAS  PubMed  Google Scholar 

  18. Foster DJ, Ravikumar P, Bellotto DJ, Unger RH, Hsia CC. Fatty diabetic lung: altered alveolar structure and surfactant protein expression. Am J Physiol Lung Cell Mol Physiol. 2010;298:L392–403.

    CAS  PubMed  PubMed Central  Google Scholar 

  19. Hsia CC, Raskin P. Lung function changes related to diabetes mellitus. Diabetes Technol Ther. 2007;9 Suppl 1:S73–82.

    PubMed  Google Scholar 

  20. Sjostrom L, Narbro K, Sjostrom CD, Karason K, Larsson B, Wedel H, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357:741–52.

    PubMed  Google Scholar 

  21. Campos EC, Peixoto-Souza FS, Alves VC, Basso-Vanelli R, Barbalho-Moulim M, Laurino-Neto RM, et al. Improvement in lung function and functional capacity in morbidly obese women subjected to bariatric surgery. Clinics (Sao Paulo). 2018;73:e20.

    PubMed Central  Google Scholar 

  22. Onofre T, Carlos R, Oliver N, Felismino A, Fialho D, Corte R, et al. Effects of a physical activity program on cardiorespiratory fitness and pulmonary function in obese women after bariatric surgery: a pilot study. Obes Surg. 2017;27:2026–33.

    PubMed  Google Scholar 

  23. Arismendi E, Rivas E, Vidal J, Barreiro E, Torralba Y, Burgos F, et al. Airway hyperresponsiveness to mannitol in obesity before and after bariatric surgery. Obes Surg. 2015;25:1666–71.

    PubMed  PubMed Central  Google Scholar 

  24. van Huisstede A, Rudolphus A, Castro Cabezas M, Biter LU, van de Geijn GJ, Taube C, et al. Effect of bariatric surgery on asthma control, lung function and bronchial and systemic inflammation in morbidly obese subjects with asthma. Thorax. 2015;70:659–67.

    PubMed  Google Scholar 

  25. Gheibi S, Kashfi K, Ghasemi A. A practical guide for induction of type-2 diabetes in rat: Incorporating a high-fat diet and streptozotocin. Biomed Pharmacother. 2017;95:605–13.

    CAS  PubMed  Google Scholar 

  26. Unger RH. Lipotoxic diseases. Annu Rev Med. 2002;53:319–36.

    CAS  PubMed  Google Scholar 

  27. Yilmaz C, Ravikumar P, Bellotto DJ, Unger RH, Hsia CC. Fatty diabetic lung: functional impairment in a model of metabolic syndrome. J Appl Physiol. 2010;109:1913–9.

    PubMed  PubMed Central  Google Scholar 

  28. Winck AD, Heinzmann-Filho JP, Soares RB, da Silva JS, Woszezenki CT, Zanatta LB. Effects of obesity on lung volume and capacity in children and adolescents: a systematic review. Rev Paul Pediatr. 2016;34:510–7.

    PubMed  PubMed Central  Google Scholar 

  29. Santos A, Rivas E, Rodríguez-Roisin R, Sánchez M, Ruiz-Cabello J, Arismendi E, et al. Lung tissue volume is elevated in obesity and reduced by bariatric surgery. Obes Surg. 2016;26:2475–82.

    PubMed  Google Scholar 

  30. Carlson EC, Audette JL, Veitenheimer NJ, Risan JA, Laturnus DI, Epstein PN. Ultrastructural morphometry of capillary basement membrane thickness in normal and transgenic diabetic mice. Anat Rec A Discov Mol Cell Evol Biol. 2003;271:332–41.

    PubMed  Google Scholar 

  31. Lash JM, Sherman WM, Hamlin RL. Capillary basement membrane thickness and capillary density in sedentary and trained obese Zucker rats. Diabetes. 1989;38:854–60.

    CAS  PubMed  Google Scholar 

  32. Chakrabarti S, Sima AA. Effect of aldose reductase inhibition and insulin treatment on retinal capillary basement membrane thickening in BB rats. Diabetes. 1989;38:1181–6.

    CAS  PubMed  Google Scholar 

  33. Burri PH, Dbaly J, Weibel ER. The postnatal growth of the rat lung. I. Morphometry. Anat Rec. 1974;178:711–30.

    CAS  PubMed  Google Scholar 

  34. Zavorsky GS, Kim DJ, Sylvestre JL, Christou NV. Alveolar-membrane diffusing capacity improves in the morbidly obese after bariatric surgery. Obes Surg. 2008;18:256–63.

    PubMed  Google Scholar 

  35. Unger RH, Orci L. Lipotoxic diseases of nonadipose tissues in obesity. Int J Obes Relat Metab Disord. 2000;24 Suppl 4:S28–32.

    CAS  PubMed  Google Scholar 

  36. Mason RJ. Biology of alveolar type II cells. Respirology. 2006;11:S12–5.

    PubMed  Google Scholar 

  37. Brown LA, Longmore WJ. Altered phospholipid secretion in type II pneumocytes isolated from streptozotocin-diabetic rats. Biochim Biophys Acta. 1986;878:258–65.

    CAS  PubMed  Google Scholar 

  38. Sugahara K, Ushijima K, Morioka T, Usuku G. Studies of the lung in diabetes mellitus. I. Ultrastructural studies of the lungs in alloxan-induced diabetic rats. Virchows Arch A Pathol Anat Histol. 1981;390:313–24.

    CAS  PubMed  Google Scholar 

  39. Boehme DS, Roberts CM, Bessman SP. High-performance liquid chromatographic analysis of lung phospholipids and their precursors in the offspring of diabetic rats. Biochem Med Metab Biol. 1990;44:29–36.

    CAS  PubMed  Google Scholar 

  40. Moore TR. A comparison of amniotic fluid fetal pulmonary phospholipids in normal and diabetic pregnancy. Am J Obstet Gynecol. 2002;186:641–50.

    PubMed  Google Scholar 

  41. Seki Y, Kasama K, Haruta H, Watanabe A, Yokoyama R, Porciuncula JPC, et al. Five-year-results of laparoscopic sleeve gastrectomy with duodenojejunal bypass for weight loss and type 2 diabetes mellitus. Obes Surg. 2017;27:795–801.

    PubMed  Google Scholar 

  42. Camastra S, Vitali A, Anselmino M, Gastaldelli A, Bellini R, Berta R, et al. Muscle and adipose tissue morphology, insulin sensitivity and beta-cell function in diabetic and nondiabetic obese patients: effects of bariatric surgery. Sci Rep. 2017;7:9007.

    PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This project was supported by the National Natural Science Foundation of China (NSFC, Grant Nos 81370496 and 81873647) and Youth Program of National Natural Science Foundation of China (Grant No. 81600059)

Author information

Authors and Affiliations

Authors

Contributions

G.Z. and J.L. conceived the experiments. G.Z., Z.Y., and J.Z. designed the experiment. Q.X. and M.Z. did the literature research. R.R. and Y.X. carried out the experiment. Y.C. and Z.M. performed the statistical analysis. Manuscript was prepared by R.R. S.H. and G.Z. had the final approval of the submitted and published version.

Corresponding author

Correspondence to Guangyong Zhang.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All study protocols were approved by the Animal Care and Utilization Committee of Shandong University.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ruze, R., Li, J., Xu, Q. et al. Sleeve gastrectomy ameliorates alveolar structures and surfactant protein expression in lungs of obese and diabetic rats. Int J Obes 44, 2394–2404 (2020). https://doi.org/10.1038/s41366-020-0647-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41366-020-0647-y

This article is cited by

Search

Quick links